An Open Label Comparing the Short Term Efficacy of Lacrisert
NCT03079271 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2017-03-14
Summary
To evaluate the short term effects of LACRISERT®. upon fluorescein corneal staining, tear osmolarity and surface topography in human subjects with dry eye disease.
Conditions
- Dry Eye
Interventions
- DRUG
-
Lacrisert, 5 Mg Ophthalmic Insert
Sponsors & Collaborators
-
Virginia Eye Consultants
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2017-06-30
- Completion
- 2017-12-31
Countries
- United States
Study Locations
More Related Trials
-
Levocarnitine for Dry Eye in Sjogren's Syndrome
NCT03953703 ·Status: COMPLETED ·Phase: PHASE2
-
TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease
NCT00848198 ·Status: COMPLETED
-
Trial of CF101 to Treat Patients With Dry Eye Disease
NCT01235234 ·Status: COMPLETED ·Phase: PHASE3
-
Diagnostic Evaluation of the Tear Film
NCT00761917 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Effectiveness of Oculeve Intranasal Lacrimal Neurostimulator in Participants With Dry Eye Syndrome
NCT02680158 ·Status: COMPLETED ·Phase: NA
-
Effect of Lifitegrast on Dry Eye Disease Signs and Symptoms
NCT03451396 ·Status: COMPLETED ·Phase: PHASE4
-
Tear Production by Nasal Neurostimulation Compared to Active Control
NCT02970799 ·Status: COMPLETED ·Phase: NA
-
Effects of NOV03 on the Tear Film
NCT05723770 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Ikervis Under Controlled Environmental Conditions Environment
NCT04492878 ·Status: COMPLETED ·Phase: PHASE4
-
Moderate-to-Severe Dry Eye Disease Relief Using Acoltremon
NCT07268599 ·Status: ENROLLING_BY_INVITATION
-
Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
NCT02798289 ·Status: COMPLETED ·Phase: NA
-
Safety and Tolerability of Artificial Tears in Dry Eye Subjects
NCT00932477 ·Status: COMPLETED ·Phase: NA
-
Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative
NCT00803387 ·Status: COMPLETED
-
Goblet Cell Response and Dry Eye Symptoms After PRK and LASIK
NCT00411827 ·Status: COMPLETED ·Phase: NA
-
Normal Lacritin Levels in Human Tears- Development of a New Clinical Assay
NCT00487643 ·Status: COMPLETED
-
Effects of 3% Diquafosol on Tear Film and Vision-related Quality of Life in Orthokeratology Lens Related Dry Eye
NCT06537349 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
NCT03925727 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Cord Blood Serum Eyes Drops Administer in Patients With Severe Keratopathy Related to EGFR-I Treatment
NCT06830551 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease
NCT05896670 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study to Clinical Evaluate Device Prototypes in Dry Eye Patients
NCT01957670 ·Status: WITHDRAWN ·Phase: NA
-
Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial
NCT05353101 ·Status: COMPLETED ·Phase: PHASE1
-
3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis® (1mg/mL Ciclosporin)
NCT04144413 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of FID 114657 in Sjogren's Syndrome Subjects
NCT01079871 ·Status: COMPLETED ·Phase: NA
-
Multicenter Trial Evaluating Quality of Tears Produced by Nasal Neurostimulation
NCT02385292 ·Status: COMPLETED ·Phase: NA